Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Medical Device Data Systems Rule Still Raising Questions

This article was originally published in The Gray Sheet

Executive Summary

While a mid-May deadline has come and gone for makers of "medical device data systems" to register their products with FDA, many are still wondering whether their offerings fall within the agency’s definition of the newly classified device category.

You may also be interested in...



Software Oversight Softened: FDA Nixes Medical Device Data Systems Enforcement

Makers of software that passively stores, transfers, formats or displays medical device data no longer need to worry about the quality system regulation or other basic device requirements for the products, according to a June 20 draft guidance.

Piecing Together The Interoperability Puzzle: Q&A With Julian Goldman

In a recent interview with “The Gray Sheet,” the founding director of the Medical Device Interoperability Program describes an ongoing effort to establish a clearer FDA pathway for devices designed to seamlessly communicate with other products, even those made by different manufacturers.

AAMI Document Will Help Explain FDA Requirements For Builders Of Medical Device Data Systems

Coming soon: A plain-language document for medical device data systems developers such as hospitals and small IT vendors that have little experience with FDA regulation.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT030214

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel